Gasgon Medical is developing AirVault, a device to remove air bubbles from IV fluids. Bubbles are disruptive to treatment time and are a potential source of harm during IV infusion. AirVault uses a unique closed air trap to keep toxic air, such as chemotherapy, safely locked away in the IV line, and without disrupting the flow rate, thereby increasing efficiency and safety for patients and healthcare providers. Gasgon, based in Cork, Ireland, plans to launch AirVault in the US and European markets in 2023. (www.gasgonmedical.com)
Gasgon Medical
Main Street
Carrigaline, Cork P43 T299
Ireland